FDA tells GLP-1 makers to warn of potential vision loss side effect The Washington PostUS FDA orders new eye risk warnings for Ozempic, Zepbound CNNGLP-1 drugs, popular for weight loss, get FDA warning of rare vision-loss side effect CBS NewsFDA adds rare vision-loss warning to popular GLP-1 drugs AP NewsUS regulator orders blindness risk warning on obesity drugs Financial Times